-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
OBJECTIVE: Basic calcium phosphate (BCP) crystals are associated with several syndromes associated with tendinopathy, including acute calcific tendonitis and Milwaukee shoulder syndrom.
Basic calcium phosphate (BCP) crystals Basic calcium phosphate (BCP) crystals Tendon disease Acute calcific tendinitis Milwaukee shoulder syndrome
Methods: In vitro experiments were used to evaluate changes in human tenocytes cultured with BCP crysta.
Tendon-related genes and extracellular matrix remodeling enzymes Tendon-related genes and extracellular matrix remodeling enzymes
Results: After 24 hours, BCP crystals upregulated tenocyte gene expression of MMP-1, MMP-3, ADAMTS-4 and TIMP-1
BCP crystals upregulate tenocyte gene expression of MMP-1, MMP-3, ADAMTS-4 and TIMP-1
Tenocytes did not alter the expression of scleral and tendon collagen, and BCP crystals did not induce the expression of proinflammatory cytokines
BCP crystals do not induce the expression of proinflammatory cytokines
Conclusions: BCP crystals induce extracellular matrix remodeling enzymes, but not inflammatory cytokines, in tenocytes
BCP crystals induce extracellular matrix remodeling enzymes but not inflammatory cytokines in tenocytes BCP crystals induce extracellular matrix remodeling enzymes but not inflammatory cytokines in tenocytes
Source:
Source:Chhana A, Pool B, Callon KE, et .
Chhana A, Pool B, Callon KE, et .
Basic calcium phosphate crystals induce the expression of extracellular matrix remodelling enzymes in tenocytes [published online ahead of print, 2022 Jul
Rheumatology (Oxfor.
2022;keac39 doi:11093 /rheumatology/keac392 leave a message here